Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
Condition:   Advanced Prostate Cancer Intervention:   Drug: Zoladex and Casodex Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin ® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Conditions:   Growth Hormone Deficiency in Children;   Born Small for Gestational Age Intervention:   Drug: Norditropin® FlexPro® Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
Conditions:   Breast Cancer Female;   Hormone Receptor Positive Malignant Neoplasm of Breast Interventions:   Drug: Palbociclib;   Drug: Endocrine therapy Sponsors:   Kyoto Breast Cancer Research Network;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2019 Category: Research Source Type: clinical trials

Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).
Condition:   Metastatic Castration-resistant Prostate Cancer (mCRPC) Interventions:   Drug: Radium-223 (Xofigo, BAY88-8223);   Drug: Abiraterone;   Drug: Enzalutamide Sponsor:   Bayer Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2019 Category: Research Source Type: clinical trials

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Combination Product: Docetaxel / Capecitabine;   Combination Product: Capecitabine / Vinorelbine;   Combination Product: Paclitaxel / Gemcitabine;   Drug: Ribociclib;   Drug: Letrozole OR Anastrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials